Overview Study of OPA-15406 Ointment in Patients With Atopic Dermatitis Status: Completed Trial end date: 2017-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the efficacy and safety of OPA-15406 ointment in patients with atopic dermatitis. Phase: Phase 2 Details Lead Sponsor: Otsuka Pharmaceutical Co., Ltd.